October is RSV Awareness Month, and it’s crucial to understand how maternal RSV vaccination can safeguard infant health. The American College of Obstetricians and Gynecologists (ACOG) plays a pivotal role in providing updated guidance for clinicians, especially regarding Pfizer’s RSV vaccine, Abrysvo.
According to ACOG, maternal RSV vaccination is a safe and effective method to prevent lower respiratory tract infections (LRTI) in infants. The recommendation is for a single dose of Pfizer’s RSV vaccine, applicable to pregnant individuals between 32 0/7 and 36 6/7 weeks of gestation who do not have a planned delivery within two weeks.
Advantia Health understands the significance of discussing these options with expecting mothers. Our providers are here to address any questions regarding RSV vaccination, emphasizing its importance alongside other respiratory virus vaccines such as COVID-19 and flu.
The Impact of Maternal RSV and COVID-19 Vaccination
The Centers for Disease Control and Prevention (CDC) released the Morbidity and Mortality Weekly Reports (MMWR), shedding light on the importance of maternal vaccinations in preventing RSV and COVID-19-related hospitalizations among infants.
The MMWR report on maternal RSV vaccination and receipt of RSV antibody revealed that health care provider recommendations significantly influenced vaccination rates. Notably, maternal COVID-19 vaccination during pregnancy can protect infants from associated hospitalizations, especially as nearly all infants hospitalized with COVID-19 did not have the protection provided by maternal vaccination.
Learning Collaborative: Protecting Infants from RSV
The Association of Immunization Managers, in collaboration with the CDC, has organized a learning collaborative call to discuss how to enhance immunization programs for equitable protection against RSV in infants. The call, centered around increasing birthing hospital participation in the Vaccines for Children program, aims to protect newborns from RSV-related risks.
Advantia Health encourages participation in such initiatives to ensure that every newborn has the opportunity for RSV protection.
Patient Education Resources
ACOG has developed valuable educational resources, including an animated video and an infographic, to inform pregnant patients about the importance of maternal RSV vaccination. These resources empower healthcare providers to counsel patients effectively and address any concerns or queries related to vaccination. Click here to watch a video about the RSV vaccine and pregnancy.
By promoting awareness and providing comprehensive information, we can ensure that maternal RSV vaccination becomes an integral part of prenatal care, ultimately safeguarding the health of newborns. Click here for more resources on The RSV Vaccine and Pregnancy.
Summary
Maternal RSV vaccination presents a crucial opportunity to protect the most vulnerable members of our society—newborns and infants. As we progress through RSV Awareness Month and beyond, it’s imperative for healthcare providers, policymakers, and communities to collaboratively emphasize and support maternal RSV vaccination. By raising awareness, promoting patient education, and ensuring equitable access to vaccination, we can make substantial strides in reducing the incidence of RSV-related hospitalizations and complications among infants.
Embracing ongoing research, leveraging educational resources, and fostering a supportive environment for expectant mothers are pivotal steps toward enhancing maternal vaccination rates. With collective effort and comprehensive understanding, we can fortify our defenses against RSV, cultivate a healthier start for our youngest generation, and pave the way for a brighter, healthier future.
Let’s join hands to prioritize maternal RSV vaccination, advancing the health and well-being of our infants today and for generations to come.